Dupuytren'sContractureTreatment near Elmhurst, NY

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Charles L. Bardes graduated from Princeton University (summa cum laude) in 1978 and from the University of Pennsylvania School of Medicine in 1986. He completed his Internal Medicine Residency training at The New York Hospital (now known as NewYork-Presbyterian Hospital) in 1989. He has served on the medical center's faculty since that time and teaches at Weill Cornell Medical College, having served as Associate Dean (Admissions) for 21 years. In addition to numerous awards for teaching and clinical care, he is a member of Phi Beta Kappa and Alpha Omega Alpha and a fellow of both The American College of Physicians and the New York Academy of Medicine. He also serves as associate editor for the Journal of General Internal Medine and The Blood Project.

Biography: Dr. Mark S. Pecker is an Attending Physician at NewYork-Presbyterian Hospital / Weill Cornell Medical Center (NYPH-WCMC) and is a Professor of Clinical Medicine and a Professor of Clinical Medicine in Physiology and Biophysics at Weill Cornell Medical College. He received his MD from New York University School of Medicine in 1977 and completed his residency in Internal Medicine at the University of Texas Southwestern Affiliated Hospitals, where he served as Chief Resident. He is certified in Internal Medicine by the American Board of Internal Medicine and a Fellow of the American College Physicians.Dr. Pecker is an American Society of Hypertension Hypertension Specialist with expertise in autonomic dysfunction, aortic dissection and secondary and endocrine hypertension. Dr. Pecker has a passion for medical training. He served as the Program Director of the Internal Medicine Residency at NYPH-WCMC for 15 years. He remains active in teaching residents and medical students in New York, as well as at Hamad General Hospital and Weill Cornell Medical College in Qatar. He helps supervise the yearly International Case Discussion Summer School in Munich, Germany, in coordination with the medical faculties of the Technical University of Munich and Ludwig Maxmillian University.At Weill Cornell he is an Associate Program Director of the Tri-Institution MD-PhD Program. He also serves as a Chair on the Translation Research Advisory Committee and as the Clinical Sciences Pathway Exploratory Advisor for the Area of Concentration Program at Weill Cornell Medicine.

Biography: Dr. Pearse is a graduate of Dartmouth College and of the combined MD/PhD program at Cornell University Medical College. He completed a Hematology and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center from 1991-1993 and was an Instructor at Memorial Sloan Kettering Cancer Center and Cornell from 1993-1998, participating in the MSKCC autologous bone marrow transplant program and lymphoma/myeloma program. He was Guest Investigator at Rockefeller from 1997-2000, where he did important and creative work on the role of TNF receptor family members in myeloma and bone biology. In 2000, he joined the Division of Hematology and Medical Oncology to join the Multiple Myeloma Program and establish a basic science laboratory.Dr. Pearse has been an attending physician in the Division of Lymphoma/Myeloma Service, Leukemia Service, and Transplant Service since 2000. He is an expert in the clinical management of hematologic malignancies, specifically myeloma, and plays an important clinical role on our autologous and allogeneic bone marrow transplantation unit.Dr. Pearse is nationally recognized for his research on the pathobiology of multiple myeloma.

Care Philosophy: As the Director of the Multiple Myeloma Center at New York Presbyterian Hospital-Cornell Medical Center, my duties will focus on providing outstanding clinical care and coordinating a world class clinical translational research program. Prestigious investigators have joined forces to create one of the leading centers for myeloma research. I have no doubt that this cooperative effort forms one of the best myeloma research groups on the World. My 25 years of experience as a myeloma physician has helped me to appreciate how important it is to treat patients in the context of a comprehensive and individualized program. New York Presbyterian Hospital has an outstanding Bone Marrow Transplant Service (a treatment modality often used for myeloma patients), performing more than 100 transplants per year. It has also been rated the best in the world in the fields of cardiology (heart), neurosurgery and nephrology (kidney). The Hospital for Special Surgery, also part of the New York Presbyterian-Weill Cornell system, has an outstanding group of orthopedic surgeons that support a new comprehensive bone disease program. In addition, as part of our continuing search for more effective therapeutic options, we offer multiple clinical trials utilizing promising new drugs and medical procedures for treating myeloma and related hematological disorders. The ultimate goal is to find the cure for multiple myeloma. The establishment of a free standing Multiple Myeloma Center at New York Presbyterian Hospital Weill Cornell Medical Center is an important step towards the accomplishment of this goal.

Care Philosophy: Clinical Electrophysiology is an exciting field with many new advancements. We have many new therapies that can help our patients feel better and live longer. It is very rewarding to be able to offer patients these new and proven therapies to make a positive impact in their lives.

Care Philosophy: The center specializes in advanced systolic and diastolic heart failure, left ventricular assist device implantation, evaluation for cardiac transplantation, vavular disease and evaluation and treatment of pulmonary hypertension. My area of clinical as well as research interest is in evaluation and management of diastolic heart failure or heart failure with preserved ejection fraction and its effects on pulmonary vasculature.

Biography: Dr. Sonal Kumar graduated summa cum laude from Washington University in St. Louis in 2002 and obtained her medical degree in 2006 from Washington University School of Medicine. She subsequently completed internal medicine internship and residency at Barnes-Jewish Hospital - Washington University School of Medicine and then Gastroenterology and Hepatology fellowship at Brigham and Women's Hospital - Harvard University. During fellowship, she also received her Master of Public Health from the Harvard School of Public Health. Dr. Kumar is board certified in Internal Medicine and Gastroenterology/Hepatology.Dr. Kumar is an Assistant Professor of Medicine and currently is the Director of Clinical Hepatology at Weill Cornell Medical College. Her clinical interests include non-alcoholic fatty liver disease, viral hepatitis, genetic/autoimmune liver disease and alcoholic liver disease. Dr. Kumar also has a background in clinical research and is involved in multiple clinical trials. She is a member of the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, the Empire Liver Foundation, and the American College of Gastroenterology. Dr. Kumar also routinely performs upper endoscopy and colonoscopy.

Biography: Dr. Evelyn Horn is the Director of the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support.Patients referred to the Center include those with diagnoses of systolic heart failure, valvular heart disease, preserved EF heart failure; pulmonary vascular disease - idiopathic, associated and secondary.Evelyn M. Horn, M.D. is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She remained at Columbia University Medical Center in the Divisions of Circulatory Physiology and Cardiology Center for Advanced Cardiac Care where she was at various times, Director of the Circulatory Physiology fellowship program, Director of Clinical Services for Heart Failure, Associate Director of the combined Pediatric & Adult Pulmonary Hypertension Center and Director of the Pulmonary Vascular program of the Center for Advanced Cardiac Care. She also was the director of the High Risk Cardiac Obstetrical program. She received numerous awards as clinician educator, continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension.The Heart Failure program provides management of advanced heart failure (both systolic and diastolic), congenital heart disease, perioperative management of conventional cardiac surgical patients (high risk patients and high risk valve surgery), and ventricular assist devices. The center also offers rare expertise in the management of pulmonary hypertension, including idiopathic pulmonary hypertension and pulmonary hypertension associated with diseases such as connective tissue disease, congenital heart disease as well as a huge number of patients who have it in association with left heart disease and others have it associated with lung disease, certain hematological diseases or liver disease. Pulmonary hypertension and right heart failure complicates the management of about 1/3 of the patients with heart failure. In many, right heart failure follows left heart failure but management of difficult "cases" may require a special expertise and understanding of the interdependence of the right and the left ventricles. If cases become complicated by secondary pulmonary hypertension or right heart failure, most of Dr. Horn's colleagues seek out the "right heart doctor," as she has sometimes been called or the combined left and right heart doc.The phenotype of heart failure has multiple etiologies, and not all heart failure behaves the same way. Because of the nuances and subtleties involved in advanced heart failure, she stresses the importance of the multidisciplinary, collaborative center. Moreover, Dr. Horn points to the center's expertise in identifying the appropriateness and the optimal timing of therapeutic interventions. "We have fantastic technologies and therapies available, but these may not be in every patient's best interest," she explains. "It is essential to understand when therapies will or will not work, and when one has to move beyond them, perhaps to mechanical assist devices or heart transplantation for heart failure and lung transplantation for pulmonary hypertension. If we wait too long, we may have missed the opportunity to treat a patient, but no one wants to resort to devices or transplantation before a patient absolutely needs it."Dr. Horn's clinical research interests have been in ventricular and vascular remodeling in pulmonary hypertension and heart failure. Specific areas have included RV imaging, pulmonary hypertension outcome studies, use of vasopressin in pulmonary hypertension, endothelial dysfunction in pulmonary hypertension, RV dysfunction in the perioperative patient population, complications of pulmonary hypertension therapy, and assessment of the non PAH pulmonary hypertension patient population. She has been actively involved in the care of patients with valvular heart disease and in particular comorbidities of ventricular dysfunction and/or pulmonary vascular disease. She has been actively involved in the care of patients needing ventricular assist device therapies as a bridging or destination device. Along with colleagues, she has authored papers in the field of newer therapies for pulmonary hypertension, epidemiological assessments of patients with pulmonary hypertension, genetics of pulmonary hypertension, and markers of vascular dysfunction. She has been involved in industry sponsored heart failure and pulmonary hypertension studies, industry sponsored investigator initiated studies and collaborative NIH studies in Heart Failure and Pulmonary Hypertension. She has also been the liaison to high risk cardiac OB programs for the care of the complicated cardiac OB patient.Research and invited lectures have been presented at major National and International meetings. She is a fellow of the International Pulmonary Vascular Research Institute, helping to establish ISLHT Pulmonary Hypertension Committee and has been the recipient of teaching awards at Columbia University. Dr. Horn has created a NY Pulmonary Hypertension consortium, a network of a dozen specialists from the tri-state area, to encourage ongoing collaborative studies in pulmonary hypertension.

Care Philosophy: Dr. Sharaiha is dedicated to putting her patients first. She has a special interest in the endoscopic treatment of obesity and the diseases of the pancreas and biliary tract, including pancreatitis, fluid collection, sphincter of oddi dysfunction and pancreatic cancer. She is grant funded for trials with malignant biliary obstruction. She sees patients for advanced endoscopic procedures, staging of GI cancers, and treatment or removal of early cancer lesions, surveillance and ablation of pancreatic cysts, and for obesity treatment.

Biography: Dr. David Wan is an Assistant Professor of Medicine and Attending Physician at the New York Presbyterian-Weill Cornell Medical Center in The Division of Gastroenterology and Hepatology.Dr. Wan earned his Bachelor of Science in Neuroscience at Brown University prior to getting his medical degree at NYU where he graduated Alpha Omega Alpha. He completed his residency in Internal Medicine at New York Presbyterian-Weill Cornell Medical Center and his Gastroenterology fellowship at NYU.Dr. Wan has a wide variety of interests within gastroenterology and hepatology. One of his main roles will be in the training of gastroenterology fellows in endoscopy/colonoscopy and the inpatient consultation service. He is a member of the American College of Gastroenterology and the American and New York Societies of Gastrointestinal Endoscopy.

Biography: Dr. Elan Goldwyn is a board certified Orthopaedic Surgeon practicing at NewYork-Presbyterian Medical Group Queens located in Fresh Meadows, NY. He received his medical degree at Albert Einstein College of Medicine Yeshiva University and completed his residency in Orthopedic Surgery. Dr. Goldwyn is the Director of Orthopedic Trauma Service at NewYork-Presbyterian Queens and is also an Assistant Professor of Clinical Orthopedic Surgery at Weill Cornell Medicine. He is certified by the American Board of Orthopaedic Surgery and chose a career in Orthopedics because musculoskeletal conditions are some of the most common and debilitating ailments we suffer from.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: Being a pediatric gastroenterologist allows me to do what I love the most -- to be able to help children with their ever-challenging gastrointestinal problems. At Weill Cornell, I am a part of a unique institution, where comprehensive patient care, family integration, and pioneering research are driving forces that subsequently help patients and their loved ones to receive the best gastrointestinal care.